Dempsey et al. present a graphene-based biosensor technology to detect enzyme activity in serum samples. A model is developed based on the activity of a panel of these biosensors to classify 90% of patients with lung cancer across all stages of disease, providing a potentially useful screening technology.
- Paul W. Dempsey
- Cristina-Mihaela Sandu
- Ole Hilberg
